Stryker's Trevo, First Retriever Indicated To Treat Acute Stroke Within 24 Hours, Earns CE Mark

Executive Summary

Stryker announced CE-mark approval of expanded labeling for its Trevo Retriever to reflect the results of the DAWN and DEFUSE 3 trials, which show that treatment of acute ischemic stroke with Trevo and standard medical therapy up to 24 hours after symptom-onset improves 90-day outcomes better than medical therapy alone. Previously, six hours was considered the maximum time from symptom onset during which this type of intervention could be effective.